127 related articles for article (PubMed ID: 25087735)
21. [Effect of nuclear factor-kappa B decoy oligodeoxynucleotides on IL-10, IL-13 and nuclear factor-kappa B protein expressions in rabbits with severe lung contusion].
Fang DQ; Yu T; Wan L
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Oct; 30(10):2284-7. PubMed ID: 20965826
[TBL] [Abstract][Full Text] [Related]
22. Enhanced intracellular uptake and inhibition of NF-kappaB activation by decoy oligonucleotide released from PLGA microspheres.
De Rosa G; Maiuri MC; Ungaro F; De Stefano D; Quaglia F; La Rotonda MI; Carnuccio R
J Gene Med; 2005 Jun; 7(6):771-81. PubMed ID: 15702489
[TBL] [Abstract][Full Text] [Related]
23. [Influence of nuclear factor-kappaB decoy oligonucleotides on RANTES expression and monocyte chemotactic activity in stromal cells of ectopic endometrium].
Wang XL; Han SP; Fang CL; Mao YD; Wang W; Lu J; Zhang HM
Zhonghua Fu Chan Ke Za Zhi; 2008 Jul; 43(7):518-22. PubMed ID: 19080516
[TBL] [Abstract][Full Text] [Related]
24. [Regulation of tissue factor expression in brain microvascular endothelial cells by PLA nanoparticles coating NF-kappaB decoy oligonucleotides].
Hu Y; Wang HF; Sun WQ; Xie CS; Wei WN; Zheng JE; Yao JX
Zhonghua Xue Ye Xue Za Zhi; 2005 Sep; 26(9):534-8. PubMed ID: 16468330
[TBL] [Abstract][Full Text] [Related]
25. Azithromycin selectively reduces tumor necrosis factor alpha levels in cystic fibrosis airway epithelial cells.
Cigana C; Assael BM; Melotti P
Antimicrob Agents Chemother; 2007 Mar; 51(3):975-81. PubMed ID: 17210769
[TBL] [Abstract][Full Text] [Related]
26. [The inhibitory effects of dumb-bell decoy oligodeoxynucleotides targeting NF-kappaB on the growth of multiple myeloma cells and IL-6 expression].
Jiang HL; Xue WJ; Liu H; Chen W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jan; 22(1):47-50. PubMed ID: 16388744
[TBL] [Abstract][Full Text] [Related]
27. [Influence of nuclear factor-kappaB decoy transfection on nuclear factor-kappaB activity and vascular endothelial growth factor/urokinase-type plasminogen activator/intercellular cell adhesion molecule-1 level of SKOV3 cells].
Lu JP; Sun H; Cao CC; Ou ZL
Zhonghua Fu Chan Ke Za Zhi; 2004 Aug; 39(8):533-7. PubMed ID: 15363352
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic effect of ribbon-type nuclear factor-κB decoy oligonucleotides in a rat model of inflammatory bowel disease.
Ozaki K; Makino H; Aoki M; Miyake T; Yasumasa N; Osako MK; Nakagami H; Rakugi H; Morishita R
Curr Gene Ther; 2012 Dec; 12(6):484-92. PubMed ID: 23061565
[TBL] [Abstract][Full Text] [Related]
29. Reduced Smad3 protein expression and altered transforming growth factor-beta1-mediated signaling in cystic fibrosis epithelial cells.
Kelley TJ; Elmer HL; Corey DA
Am J Respir Cell Mol Biol; 2001 Dec; 25(6):732-8. PubMed ID: 11726399
[TBL] [Abstract][Full Text] [Related]
30. Impairment of NFkappaB activity by unsaturated fatty acids.
Schumann J; Fuhrmann H
Int Immunopharmacol; 2010 Aug; 10(8):978-84. PubMed ID: 20580946
[TBL] [Abstract][Full Text] [Related]
31. Cell death in NF-kappaB-dependent tumour cell lines as a result of NF-kappaB trapping by linker-modified hairpin decoy oligonucleotide.
Laguillier C; Hbibi AT; Baran-Marszak F; Metelev V; Cao A; Cymbalista F; Bogdanov A; Fagard R
FEBS Lett; 2007 Mar; 581(6):1143-50. PubMed ID: 17328896
[TBL] [Abstract][Full Text] [Related]
32. Ibuprofen modulates NF-kB activity but not IL-8 production in cystic fibrosis respiratory epithelial cells.
Dauletbaev N; Lam J; Eklove D; Iskandar M; Lands LC
Respiration; 2010; 79(3):234-42. PubMed ID: 19887769
[TBL] [Abstract][Full Text] [Related]
33. Lung mesenchymal stem cells-derived extracellular vesicles attenuate the inflammatory profile of Cystic Fibrosis epithelial cells.
Zulueta A; Colombo M; Peli V; Falleni M; Tosi D; Ricciardi M; Baisi A; Bulfamante G; Chiaramonte R; Caretti A
Cell Signal; 2018 Nov; 51():110-118. PubMed ID: 30076968
[TBL] [Abstract][Full Text] [Related]
34. Treatment of murine Th1- and Th2-mediated inflammatory bowel disease with NF-kappa B decoy oligonucleotides.
Fichtner-Feigl S; Fuss IJ; Preiss JC; Strober W; Kitani A
J Clin Invest; 2005 Nov; 115(11):3057-71. PubMed ID: 16239967
[TBL] [Abstract][Full Text] [Related]
35. A disease-relevant high-content screening assay to identify anti-inflammatory compounds for use in cystic fibrosis.
Giddings AM; Maitra R
J Biomol Screen; 2010 Dec; 15(10):1204-10. PubMed ID: 20944057
[TBL] [Abstract][Full Text] [Related]
36. Anti-inflammatory effect of miglustat in bronchial epithelial cells.
Dechecchi MC; Nicolis E; Norez C; Bezzerri V; Borgatti M; Mancini I; Rizzotti P; Ribeiro CM; Gambari R; Becq F; Cabrini G
J Cyst Fibros; 2008 Nov; 7(6):555-65. PubMed ID: 18815075
[TBL] [Abstract][Full Text] [Related]
37. New treatment of periodontal diseases by using NF-kappaB decoy oligodeoxynucleotides via prevention of bone resorption and promotion of wound healing.
Shimizu H; Nakagami H; Morita S; Tsukamoto I; Osako MK; Nakagami F; Shimosato T; Minobe N; Morishita R
Antioxid Redox Signal; 2009 Sep; 11(9):2065-75. PubMed ID: 19186992
[TBL] [Abstract][Full Text] [Related]
38. Cytidine-phosphate-guanosine oligonucleotides induce interleukin-8 production through activation of TLR9, MyD88, NF-κB, and ERK pathways in odontoblast cells.
He W; Zhang Y; Zhang J; Yu Q; Wang P; Wang Z; Smith AJ
J Endod; 2012 Jun; 38(6):780-5. PubMed ID: 22595112
[TBL] [Abstract][Full Text] [Related]
39. Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappaB decoy oligodeoxynucleotides as a gene therapy.
Tomita T; Takeuchi E; Tomita N; Morishita R; Kaneko M; Yamamoto K; Nakase T; Seki H; Kato K; Kaneda Y; Ochi T
Arthritis Rheum; 1999 Dec; 42(12):2532-42. PubMed ID: 10615998
[TBL] [Abstract][Full Text] [Related]
40. Effects of chimeric decoy oligodeoxynucleotide in the regulation of transcription factors NF-κB and Sp1 in an animal model of atherosclerosis.
Lee WR; Kim KH; An HJ; Park YY; Kim KS; Lee CK; Min BK; Park KK
Basic Clin Pharmacol Toxicol; 2013 Apr; 112(4):236-43. PubMed ID: 23107157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
